Literature DB >> 23278307

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.

George A Follows, Hannah Sims, David M Bloxham, Thorsten Zenz, Melanie A Hopper, Hongxiang Liu, Anthony Bench, Penny Wright, Mars B Van't Veer, Mike A Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23278307     DOI: 10.1111/bjh.12201

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  24 in total

Review 1.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 2.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

3.  Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.

Authors:  Eszter Sári; Zsolt György Nagy; Kornélia Baghy; Hajnalka Rajnai; Csaba Bödör; Judit Csomor; Gábor Barna; Gábor Rudas; Ilona Kovalszky; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

4.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

5.  Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.

Authors:  Dalia A Salem; Drake Scott; Catharine S McCoy; David J Liewehr; David J Venzon; Evgeny Arons; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2019-05-11       Impact factor: 3.058

6.  Removing a hair of doubt about BRAF targeting.

Authors:  Robert J Kreitman
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

Review 7.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

8.  BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

Authors:  Svetlana A Protsenko; Anna I Semionova; Yuri I Komarov; Svetlana N Aleksakhina; Alexandr O Ivantsov; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Invest New Drugs       Date:  2015-08-20       Impact factor: 3.850

Review 9.  Hairy cell leukemia-new genes, new targets.

Authors:  Robert J Kreitman
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

Review 10.  ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

Authors:  Priscilla K Brastianos; Sandro Santagata
Journal:  Eur J Endocrinol       Date:  2015-11-12       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.